Life ScienceCompany
Novartis has acquired 31 companies, including 11 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 6 assets.
Novartis’ largest acquisition to date was in 2019, when it acquired The Medicines Company for $9.7B. It’s largest disclosed sale occurred in 2014, when it sold Novartis Animal Health to Eli Lilly for $5.4B. Novartis has acquired in 10 different US states, and 5 countries. The Company’s most targeted sectors include life science (82%) and medical products (12%).
Join Mergr and gain access to Novartis’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity33
- M&A Buy Activity27
- M&A Sell Activity6
- Total Sectors Invested 4
- Total Countries Invested 5
- M&A Buy/Sell Connections 18
- M&A Advisors 1